Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360956056> ?p ?o ?g. }
- W4360956056 endingPage "699.e1" @default.
- W4360956056 startingPage "692" @default.
- W4360956056 abstract "ObjectiveChronic venous hypertension, triggered by venous reflux and/or obstruction, leads to skin changes and venous leg ulcers (VLUs). Compression therapy is the standard of care, but many wounds remain unhealed. The objectives of this study were to observe the effects of endovenous chemical ablation with commercially available 1% polidocanol injectable microfoam on VLU healing and recurrence rates.MethodsThe VIEW VLU study was a multicenter, open-label, phase IV registry of patients with active VLUs resulting from venous insufficiency of the great saphenous vein and/or anterior accessory saphenous vein systems who underwent ablation with 1% polidocanol microfoam. Primary outcomes included wound healing rate (change in wound perimeter), wound closure at 12 weeks after treatment, and time to wound closure. Secondary outcomes included VLU recurrence, numeric pain score at the ulcer location, EuroQol five-dimension five-level questionnaire quality-of-life index, and the Venous Clinical Severity Score. Patients were followed for 12 months.ResultsWe enrolled 76 patients (80 ulcers) from 14 sites across the United States and Canada (mean age 63.6 ± 13.7 years, 39.5% female, mean body mass index 36.3). Of the enrollees, 96.3% presented with great saphenous vein incompetence. The mean baseline wound perimeter was 117.2 ± 107.4 mm and 26.3% of wounds (21/80) were circumferential. The mean ulcer age was 34.8 ± 51.8 weeks at first presentation and the mean compression therapy duration was 26.4 ± 35.9 weeks. The median wound perimeter decreased by 16.3% from baseline in the first 2 weeks after the procedure and by 27.0% at 12 weeks. By 12 weeks, 53.8% of wounds (43/80) were healed. The median time to ulcer closure by Kaplan-Meier analysis was 89 days (95% confidence interval, 62.0-117.0). In a Kaplan-Meier analysis of initially healed wounds, 88.9% (95% confidence interval, 76.9-94.8) remained closed at 12 weeks after closure. The mean numeric pain scores (ulcer site) improved by 41.0% and 64.1% at 12 weeks and 12 months after the procedure, respectively. The health-related quality-of-life index (scale of 0-1) improved from 0.65 ± 0.27 at baseline to 0.72 ± 0.28 at 12 weeks and 0.73 ± 0.30 at 12 months. By 12 weeks after treatment, the mean target leg Venous Clinical Severity Score had significantly decreased by 5.8 points, and by 12 months it had decreased by 10.0 points.ConclusionsTreatment with 1% polidocanol microfoam was associated with promising wound healing rates and low recurrence rates for VLUs, despite a challenging patient population with recalcitrant ulcers, a large percentage of which were circumferential, in patients with high body mass indexes." @default.
- W4360956056 created "2023-03-26" @default.
- W4360956056 creator A5011095648 @default.
- W4360956056 creator A5027183470 @default.
- W4360956056 creator A5031431059 @default.
- W4360956056 creator A5037627466 @default.
- W4360956056 creator A5040867863 @default.
- W4360956056 creator A5042378459 @default.
- W4360956056 creator A5046454572 @default.
- W4360956056 creator A5052341088 @default.
- W4360956056 creator A5071067295 @default.
- W4360956056 creator A5073089884 @default.
- W4360956056 creator A5074307831 @default.
- W4360956056 creator A5078151265 @default.
- W4360956056 creator A5081185854 @default.
- W4360956056 creator A5089317996 @default.
- W4360956056 date "2023-07-01" @default.
- W4360956056 modified "2023-10-16" @default.
- W4360956056 title "VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers" @default.
- W4360956056 cites W1574700853 @default.
- W4360956056 cites W1963767071 @default.
- W4360956056 cites W1992585421 @default.
- W4360956056 cites W2000841294 @default.
- W4360956056 cites W2019733175 @default.
- W4360956056 cites W2047384553 @default.
- W4360956056 cites W2062151389 @default.
- W4360956056 cites W2106792599 @default.
- W4360956056 cites W2122531041 @default.
- W4360956056 cites W2136139586 @default.
- W4360956056 cites W2154948225 @default.
- W4360956056 cites W2295163033 @default.
- W4360956056 cites W2342073676 @default.
- W4360956056 cites W2400166990 @default.
- W4360956056 cites W2802332683 @default.
- W4360956056 cites W2947820147 @default.
- W4360956056 cites W3009012105 @default.
- W4360956056 cites W4320301267 @default.
- W4360956056 doi "https://doi.org/10.1016/j.jvsv.2023.01.011" @default.
- W4360956056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36972751" @default.
- W4360956056 hasPublicationYear "2023" @default.
- W4360956056 type Work @default.
- W4360956056 citedByCount "2" @default.
- W4360956056 countsByYear W43609560562023 @default.
- W4360956056 crossrefType "journal-article" @default.
- W4360956056 hasAuthorship W4360956056A5011095648 @default.
- W4360956056 hasAuthorship W4360956056A5027183470 @default.
- W4360956056 hasAuthorship W4360956056A5031431059 @default.
- W4360956056 hasAuthorship W4360956056A5037627466 @default.
- W4360956056 hasAuthorship W4360956056A5040867863 @default.
- W4360956056 hasAuthorship W4360956056A5042378459 @default.
- W4360956056 hasAuthorship W4360956056A5046454572 @default.
- W4360956056 hasAuthorship W4360956056A5052341088 @default.
- W4360956056 hasAuthorship W4360956056A5071067295 @default.
- W4360956056 hasAuthorship W4360956056A5073089884 @default.
- W4360956056 hasAuthorship W4360956056A5074307831 @default.
- W4360956056 hasAuthorship W4360956056A5078151265 @default.
- W4360956056 hasAuthorship W4360956056A5081185854 @default.
- W4360956056 hasAuthorship W4360956056A5089317996 @default.
- W4360956056 hasBestOaLocation W43609560561 @default.
- W4360956056 hasConcept C126322002 @default.
- W4360956056 hasConcept C141071460 @default.
- W4360956056 hasConcept C159110408 @default.
- W4360956056 hasConcept C2776106345 @default.
- W4360956056 hasConcept C2777202286 @default.
- W4360956056 hasConcept C2778230777 @default.
- W4360956056 hasConcept C2778890739 @default.
- W4360956056 hasConcept C2779480337 @default.
- W4360956056 hasConcept C2779951463 @default.
- W4360956056 hasConcept C2780221984 @default.
- W4360956056 hasConcept C2780868729 @default.
- W4360956056 hasConcept C2780950165 @default.
- W4360956056 hasConcept C2780952370 @default.
- W4360956056 hasConcept C2910471476 @default.
- W4360956056 hasConcept C71924100 @default.
- W4360956056 hasConceptScore W4360956056C126322002 @default.
- W4360956056 hasConceptScore W4360956056C141071460 @default.
- W4360956056 hasConceptScore W4360956056C159110408 @default.
- W4360956056 hasConceptScore W4360956056C2776106345 @default.
- W4360956056 hasConceptScore W4360956056C2777202286 @default.
- W4360956056 hasConceptScore W4360956056C2778230777 @default.
- W4360956056 hasConceptScore W4360956056C2778890739 @default.
- W4360956056 hasConceptScore W4360956056C2779480337 @default.
- W4360956056 hasConceptScore W4360956056C2779951463 @default.
- W4360956056 hasConceptScore W4360956056C2780221984 @default.
- W4360956056 hasConceptScore W4360956056C2780868729 @default.
- W4360956056 hasConceptScore W4360956056C2780950165 @default.
- W4360956056 hasConceptScore W4360956056C2780952370 @default.
- W4360956056 hasConceptScore W4360956056C2910471476 @default.
- W4360956056 hasConceptScore W4360956056C71924100 @default.
- W4360956056 hasFunder F4320310567 @default.
- W4360956056 hasIssue "4" @default.
- W4360956056 hasLocation W43609560561 @default.
- W4360956056 hasLocation W43609560562 @default.
- W4360956056 hasOpenAccess W4360956056 @default.
- W4360956056 hasPrimaryLocation W43609560561 @default.
- W4360956056 hasRelatedWork W1877853587 @default.
- W4360956056 hasRelatedWork W2999334161 @default.
- W4360956056 hasRelatedWork W3009755280 @default.